基础医学与临床 ›› 2010, Vol. 30 ›› Issue (11): 1222-1225.

• 短篇综述 • 上一篇    下一篇

骨髓间充质干细胞对肝病的治疗作用

张千 邓存良   

  1. 泸州医学院附属医院感染科 泸州医学院附属医院感染科
  • 收稿日期:2009-10-19 修回日期:2010-01-22 出版日期:2010-11-05 发布日期:2010-11-05
  • 通讯作者: 邓存良

The treatment of mesenchymal stem cells in hepatic disease

Qian ZHANG, Cun-liang DENG   

  1. Luzhou Medical College Luzhou Medical College
  • Received:2009-10-19 Revised:2010-01-22 Online:2010-11-05 Published:2010-11-05
  • Contact: Cun-liang DENG

摘要: 骨髓间充质干细胞(MSCs)是一群具有多向分化潜能的成体干细胞,具有抑制T细胞活化、调节异体移植的免疫耐受等免疫特性。肝移植是各种晚期肝病的主要治疗方法,但由于器官来源的缺乏和伴随的免疫排斥反应,其应用受到限制。研究证明骨髓是肝祖细胞的来源之一,在一定的条件下,骨髓间充质干细胞能够分化为功能性肝细胞并分泌相关细胞因子,促进肝细胞的再生,为临床治疗各种肝损害提供了新的途径。

Abstract: Mesenchymal stem cells are multipotent stem cells,they have specific immune characteristics,for example,they could suppress activation of T cells and modulate immune tolerance of allogeneic transplants. Liver transplantation is the primary treatment for various end-stage hepatic diseases but is hindered by the lack of donor organs and by complications associated with rejection and immunosuppression. Studys have shown that bone marrow is one of transplantable source of hepatic progenitors. Multipotent bone marrow-derived mesenchymal stem cells can differentiate into functional hepatocyts,secrete related cytokines promoting regeneration of the hepatocytes under defined conditions, it provides a new way for treating kinds of liver injury.The function of mesenchymal stem cells for hepatic disease is discussed in this review.